$KGKG
KONA GOLD BEVERAGE, INC. Stock $kgkg

$kgkg Overview Financials Valuation SEC Filings Company Website

2022 Q3 Form 10-Q Financial Statement

#000149315222022436 Filed on August 12, 2022

Income Statement

Concept	2022 Q3	2022 Q2	2022 Q1
Revenue	$1.131M	$1.173M	$995.1K
YoY Change	107.3%	48.38%	115.21%
Cost Of Revenue	$873.3K	$885.5K	$849.9K
YoY Change	97.24%	28.95%	170.73%
Gross Profit	$257.2K	$287.9K	$145.3K
YoY Change	150.69%	176.53%	-2.18%
Gross Profit Margin	22.75%	24.53%	14.6%
Selling, General & Admin	$1.075M	$1.032M	$939.3K
YoY Change	42.18%	60.16%	65.09%
% of Gross Profit	417.94%	358.31%	646.68%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$25.21K	$22.95K	$26.18K
YoY Change	101.68%	116.59%	164.26%
% of Gross Profit	9.8%	7.97%	18.02%
Operating Expenses	$1.075M	$1.032M	$939.3K
YoY Change	42.18%	60.16%	-73.82%
Operating Profit	-$817.8K	-$743.6K	-$794.1K
YoY Change	25.14%	37.72%	88.85%
Interest Expense	$253.9K	$156.5K	$430.9K
YoY Change	1380.29%	140.87%	1054.01%
% of Operating Profit
Other Income/Expense, Net	-$374.2K	$1.798K	$3.224K
YoY Change
Pretax Income	-$1.192M	-$1.390M	-$3.565M
YoY Change	-46.07%	-36.37%	96.17%
Income Tax	-$430.00	-$1.800K	-$3.220K
% Of Pretax Income
Net Earnings	-$1.192M	-$1.389M	-$3.562M
YoY Change	-46.56%	272.05%	95.74%
Net Earnings / Revenue	-105.44%	-118.33%	-357.9%
Basic Earnings Per Share	$0.00	$0.00	$0.00
Diluted Earnings Per Share	-$677.10	-$889.90	-$3.065K
COMMON SHARES
Basic Shares Outstanding	1.781B shares	1.560B shares	1.162B shares
Diluted Shares Outstanding	1.761B shares	1.560B shares

Balance Sheet

Concept	2022 Q3	2022 Q2	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$270.8K	$6.190K	$296.8K
YoY Change	-50.45%	-93.45%	428.1%
Cash & Equivalents	$270.8K	$6.188K	$296.8K
Short-Term Investments
Other Short-Term Assets	$17.90K	$59.83K	$28.81K
YoY Change	174.64%	626.67%	283.2%
Inventory	$1.008M	$1.190M	$1.129M
Prepaid Expenses			$11.37K
Receivables	$56.11K	$24.94K	$94.13K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$1.353M	$1.281M	$1.560M
YoY Change	-13.32%	5.48%	48.34%
LONG-TERM ASSETS
Property, Plant & Equipment	$370.5K	$328.0K	$345.4K
YoY Change	31.84%	88.9%	95.2%
Goodwill
YoY Change
Intangibles	$68.64K	$71.08K	$73.52K
YoY Change
Long-Term Investments
YoY Change
Other Assets	$15.13K	$15.13K	$15.13K
YoY Change	-99.44%	132.77%	132.77%
Total Long-Term Assets	$1.278M	$1.285M	$1.352M
YoY Change	-55.37%	-45.83%	-44.05%
TOTAL ASSETS
Total Short-Term Assets	$1.353M	$1.281M	$1.560M
Total Long-Term Assets	$1.278M	$1.285M	$1.352M
Total Assets	$2.631M	$2.566M	$2.912M
YoY Change	-40.54%	-28.45%	-16.03%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.041M	$854.4K	$1.072M
YoY Change	405.05%	143.78%	315.82%
Accrued Expenses	$376.8K	$443.8K	$500.9K
YoY Change	105.03%	224.72%	376.93%
Deferred Revenue
YoY Change
Short-Term Debt	$530.6K	$84.73K	$652.6K
YoY Change	-77.89%	-93.48%	-45.62%
Long-Term Debt Due	$2.266M	$1.927M	$344.9K
YoY Change	64840.11%	32016.33%	3732.33%
Total Short-Term Liabilities	$5.231M	$4.203M	$4.502M
YoY Change	-10.45%	2.04%	11.91%
LONG-TERM LIABILITIES
Long-Term Debt	$71.75K	$22.22K	$1.376M
YoY Change	-97.1%	-99.18%	-50.99%
Other Long-Term Liabilities		$606.7K	$615.3K
YoY Change		-20.54%	-19.42%
Total Long-Term Liabilities	$0.00	$606.7K	$615.3K
YoY Change	-100.0%	-82.45%	-82.77%
TOTAL LIABILITIES
Total Short-Term Liabilities	$5.231M	$4.203M	$4.502M
Total Long-Term Liabilities	$0.00	$606.7K	$615.3K
Total Liabilities	$5.980M	$5.557M	$7.274M
YoY Change	-36.98%	-26.66%	-4.22%
SHAREHOLDERS EQUITY
Retained Earnings	-$22.44M	-$21.25M	-$19.86M
YoY Change	63.77%	85.22%	78.94%
Common Stock	$18.07K	$17.09K	$14.83K
YoY Change	104.56%	100.88%	79.58%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$3.350M	-$2.991M	-$4.362M
YoY Change
Total Liabilities & Shareholders Equity	$2.631M	$2.566M	$2.912M
YoY Change	-40.54%	-28.45%	-16.03%

Cashflow Statement

Concept	2022 Q3	2022 Q2	2022 Q1
OPERATING ACTIVITIES
Net Income	-$1.192M	-$1.389M	-$3.562M
YoY Change	-46.56%	272.05%	95.74%
Depreciation, Depletion And Amortization	$25.21K	$22.95K	$26.18K
YoY Change	101.68%	116.59%	164.26%
Cash From Operating Activities	-$529.2K	-$949.9K	-$669.5K
YoY Change	-25.58%	110.53%	57.76%
INVESTING ACTIVITIES
Capital Expenditures	-$18.75K	-$3.040K	$21.13K
YoY Change	-84.33%	-49.16%	4.27%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00	$0.00
YoY Change	-100.0%	-100.0%	-100.0%
Cash From Investing Activities	-$18.75K	-$3.040K	-$21.13K
YoY Change	-84.02%	-16.25%	-98.38%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	812.6K	662.3K	$283.6K
YoY Change	-36.54%	33.5%	-83.02%
NET CHANGE
Cash From Operating Activities	-529.2K	-949.9K	-$669.5K
Cash From Investing Activities	-18.75K	-3.040K	-$21.13K
Cash From Financing Activities	812.6K	662.3K	$283.6K
Net Change In Cash	264.6K	-290.6K	-$407.0K
YoY Change	-41.46%	-803.83%	578.76%
FREE CASH FLOW
Cash From Operating Activities	-$529.2K	-$949.9K	-$669.5K
Capital Expenditures	-$18.75K	-$3.040K	$21.13K
Free Cash Flow	-$510.5K	-$946.8K	-$690.6K
YoY Change	-13.69%	112.68%	55.32%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q2	KGKG	Eidl Advance EidlAdvance		usd
	KGKG	Eidl Advance EidlAdvance		usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium		usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets		usd
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite A
	dei	Entity Central Index Key EntityCentralIndexKey	0001802546
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts		usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
	KGKG	Loss On Change In Fair Value Of Derivative Liabilities LossOnChangeInFairValueOfDerivativeLiabilities		usd
	KGKG	Interest Expense Related To Warrants On Convertible Debt InterestExpenseRelatedToWarrantsOnConvertibleDebt		usd
	KGKG	Common Stock Issued For Acquisition CommonStockIssuedForAcquisition		usd
	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities		usd
	KGKG	Payments For Proceeds From In Intellectual Property PaymentsForProceedsFromInIntellectualProperty		usd
	KGKG	Repayments Of Long Term Lines Of Credits RepaymentsOfLongTermLinesOfCredits		usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments		usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt		usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable		usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable		usd
	KGKG	Proceeds From Ppp Notes Payable ProceedsFromPppNotesPayable		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	us-gaap	Stock Issued1 StockIssued1		usd
	KGKG	Common Shares Issued On Conversion Of Debentures And Accrued Interest CommonSharesIssuedOnConversionOfDebenturesAndAccruedInterest		usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets		usd
CY2022Q2	us-gaap	Notes Payable Related Parties Noncurrent NotesPayableRelatedPartiesNoncurrent		usd
CY2021Q4	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent		usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised		shares
	KGKG	Share Based Compensation Arrangements By Share Based Payment Award Non Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisesInPeriodWeightedAverageExercisePrice
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures		shares
	KGKG	Share Based Compensation Arrangements By Share Based Payment Award Non Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsForfeituresInPeriodWeightedAverageExercisePrice
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-06-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	000-56230
	dei	Entity Registrant Name EntityRegistrantName	KONA GOLD BEVERAGE, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	81-5175120
	dei	Entity Address Address Line1 EntityAddressAddressLine1	746 North Drive
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Address City Or Town EntityAddressCityOrTown	Melbourne
	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	32934
	dei	City Area Code CityAreaCode	(844)
	dei	Local Phone Number LocalPhoneNumber	714-2224
	dei	Security12b Title Security12bTitle	Common Stock
	dei	Trading Symbol TradingSymbol	KGKG
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	1781156866	shares
CY2022Q2	us-gaap	Cash Cash	6188	usd
CY2021Q4	us-gaap	Cash Cash	703825	usd
CY2022Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	11961	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	11926	usd
CY2022Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	24943	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	15993	usd
CY2022Q2	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	150000	usd
CY2021Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	150000	usd
CY2022Q2	us-gaap	Inventory Net InventoryNet	1189913	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	574811	usd
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	278707	usd
CY2022Q2	us-gaap	Other Assets Current OtherAssetsCurrent	59834	usd
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	30373	usd
CY2022Q2	us-gaap	Assets Current AssetsCurrent	1280878	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	1603709	usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	327955	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	348037	usd
CY2022Q2	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	870736	usd
CY2021Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	966955	usd
CY2022Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	71078	usd
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	75955	usd
CY2022Q2	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	15125	usd
CY2021Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	15125	usd
CY2022Q2	us-gaap	Assets Assets	2565772	usd
CY2021Q4	us-gaap	Assets Assets	3009781	usd
CY2022Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	854360	usd
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	541123	usd
CY2022Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	219583	usd
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	329583	usd
CY2022Q2	us-gaap	Notes Payable Current NotesPayableCurrent	198332	usd
CY2021Q4	us-gaap	Notes Payable Current NotesPayableCurrent	7974	usd
CY2022Q2	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	1728651	usd
CY2021Q4	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	6000	usd
CY2022Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	60000	usd
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	60000	usd
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	224162	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	213837	usd
CY2022Q2	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	84730	usd
CY2021Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	849933	usd
CY2022Q2	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	833000	usd
CY2021Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	2121000	usd
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	4202818	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4129450	usd
CY2021Q4	us-gaap	Notes Payable Related Parties Noncurrent NotesPayableRelatedPartiesNoncurrent	1525651	usd
CY2022Q2	us-gaap	Long Term Notes Payable LongTermNotesPayable	22219	usd
CY2021Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	25338	usd
CY2022Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	606731	usd
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	615317	usd
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	725284	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	838883	usd
CY2022Q2	us-gaap	Liabilities Liabilities	5557052	usd
CY2021Q4	us-gaap	Liabilities Liabilities	7134639	usd
CY2022Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2022Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5700250	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5700250	shares
CY2022Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	988000	shares
CY2022Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	988000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	988000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	988000	shares
CY2022Q2	us-gaap	Preferred Stock Value PreferredStockValue	10	usd
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue	10	usd
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	2500000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	2500000000	shares
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1709122945	shares
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1709122945	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1004709546	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1004709546	shares
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	17091	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	10047	usd
CY2022Q2	KGKG	Common Stock Issuable Shares CommonStockIssuableShares	170000000	shares
CY2021Q4	KGKG	Common Stock Issuable Shares CommonStockIssuableShares	170000000	shares
CY2022Q2	KGKG	Common Stock Issuable CommonStockIssuable	1386497	usd
CY2021Q4	KGKG	Common Stock Issuable CommonStockIssuable	1386497	usd
CY2022Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	16855382	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	10778761	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-21250260	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-16300173	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	-2991280	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-4124858	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2565772	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3009781	usd
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1173398	usd
CY2021Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	790809	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2168529	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1252980	usd
CY2022Q2	us-gaap	Cost Of Revenue CostOfRevenue	885517	usd
CY2021Q2	us-gaap	Cost Of Revenue CostOfRevenue	686706	usd
	us-gaap	Cost Of Revenue CostOfRevenue	1735393	usd
	us-gaap	Cost Of Revenue CostOfRevenue	1000571	usd
CY2022Q2	us-gaap	Gross Profit GrossProfit	287881	usd
CY2021Q2	us-gaap	Gross Profit GrossProfit	104103	usd
	us-gaap	Gross Profit GrossProfit	433136	usd
	us-gaap	Gross Profit GrossProfit	252409	usd
CY2022Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1031515	usd
CY2021Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	644052	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1970851	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1212732	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-743634	usd
CY2021Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-539949	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1537715	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-960323	usd
CY2022Q2	us-gaap	Interest Expense InterestExpense	156459	usd
CY2021Q2	us-gaap	Interest Expense InterestExpense	64956	usd
	us-gaap	Interest Expense InterestExpense	587354	usd
	us-gaap	Interest Expense InterestExpense	1195866	usd
CY2022Q2	KGKG	Financing Cost Expense FinancingCostExpense	286000	usd
	KGKG	Financing Cost Expense FinancingCostExpense	286000	usd
CY2022Q2	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	122000	usd
CY2021Q2	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	141497	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-1671000	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-124369	usd
CY2022Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-326230	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-873040	usd
CY2022Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1798	usd
CY2021Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-4967	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	5022	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-7542	usd
CY2021Q2	KGKG	Eidl Advance EidlAdvance	-95161	usd
	KGKG	Eidl Advance EidlAdvance	-95161	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-1388525	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-373214	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4950087	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2192939	usd
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1560391543	shares
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	805263473	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1363761068	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	805263473	shares
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	-4362006	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	2669751	usd
CY2022Q2	KGKG	Stock Issued During Period Value Common Stock Issued With Employment Agreement StockIssuedDuringPeriodValueCommonStockIssuedWithEmploymentAgreement	8500	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	81000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-1388525	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	-2991280	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-4124858	usd
	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	5859165	usd
	KGKG	Stock Issued During Period Value Common Stock Issued With Note Payable Received As Debt Discount StockIssuedDuringPeriodValueCommonStockIssuedWithNotePayableReceivedAsDebtDiscount	135000	usd
	KGKG	Stock Issued During Period Value Common Stock Issued With Employment Agreement StockIssuedDuringPeriodValueCommonStockIssuedWithEmploymentAgreement	8500	usd
	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	81000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4950087	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	-2991280	usd
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	-2470098	usd
CY2021Q2	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	509174	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-373214	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	-2604138	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-2857654	usd
	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	1122984	usd
	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	270900	usd
	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	1052571	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2192939	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	-2604138	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4950087	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2192939	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	44250	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	20503	usd
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	96219	usd
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	74261	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	480763	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	4877	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	35	usd
	KGKG	Financing Costs FinancingCosts	286000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-873040	usd
	KGKG	Loss On Change In Fair Value Of Derivative Liabilities LossOnChangeInFairValueOfDerivativeLiabilities	-1671000	usd
	KGKG	Interest Expense Related To Warrants On Convertible Debt InterestExpenseRelatedToWarrantsOnConvertibleDebt	1052571	usd
	KGKG	Common Stock Issued For Compensation CommonStockIssuedForCompensation	8500	usd
	KGKG	Common Stock Issued For Acquisition CommonStockIssuedForAcquisition	270900	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	8985	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	344030	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	615102	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	92447	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-278707	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	10244	usd
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	29461	usd
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	2662	usd
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	450365	usd
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	180716	usd
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-110000	usd
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	117708	usd
	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities	124369	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-99476	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-74261	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1619355	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-875555	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	24168	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	26247	usd
	KGKG	Payments For Proceeds From Goodwill PaymentsForProceedsFromGoodwill	1275938	usd
	KGKG	Payments For Proceeds From In Intellectual Property PaymentsForProceedsFromInIntellectualProperty	7604	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-24168	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1309789	usd
	KGKG	Repayments Of Long Term Lines Of Credits RepaymentsOfLongTermLinesOfCredits	-3000	usd
	KGKG	Proceeds From Payment Of Acquisition Obligation ProceedsFromPaymentOfAcquisitionObligation	8586	usd
	KGKG	Proceeds From Payment Of Acquisition Obligation ProceedsFromPaymentOfAcquisitionObligation	-624360	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	3798	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	200000	usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	3000	usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	6000	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	289389	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	3119	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	475000	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	1522984	usd
	KGKG	Proceeds From Ppp Notes Payable ProceedsFromPppNotesPayable	22326	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	945886	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2166670	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-697637	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-18674	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	703825	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	113168	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	6188	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	94494	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	2275	usd
	us-gaap	Interest Paid Net InterestPaidNet	256	usd
	us-gaap	Interest Paid Net InterestPaidNet	34941	usd
	us-gaap	Stock Issued1 StockIssued1	135000	usd
	KGKG	Common Shares Issued On Conversion Of Debentures And Accrued Interest CommonSharesIssuedOnConversionOfDebenturesAndAccruedInterest	5859165	usd
	KGKG	Derivative Liability Recorded On Issuance Of Convertible Note DerivativeLiabilityRecordedOnIssuanceOfConvertibleNote	680000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4950087	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1619355	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	-2991280	usd
CY2022Q2	us-gaap	Cash Cash	6188	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_847_eus-gaap--UseOfEstimates_zh6cUB7wNNy2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_860_zZzYKXBPfP4a">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosures of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Those estimates and assumptions include estimates for reserves of uncollectible accounts receivable, assumptions used in valuing inventories at net realizable value, impairment testing of recorded long-term tangible and intangible assets, the valuation allowance for deferred tax assets, accruals for potential liabilities, assumptions made in valuing stock instruments issued for services, and assumptions used in valuing warrant liabilities, and assumptions used in the determination of the Company’s liquidity.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
	KGKG	Sales Percentage SalesPercentage	0.03	pure
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1173398	usd
CY2021Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	790809	usd
CY2022Q2	KGKG	Revenue From Contract With Customer Excluding Assessed Tax Percentage RevenueFromContractWithCustomerExcludingAssessedTaxPercentage	0.48	pure
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2168529	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1252980	usd
	KGKG	Revenue From Contract With Customer Excluding Assessed Tax Percentage RevenueFromContractWithCustomerExcludingAssessedTaxPercentage	0.73	pure
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1173398	usd
CY2021Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	790809	usd
CY2022Q2	KGKG	Revenue From Contract With Customer Excluding Assessed Tax Percentage RevenueFromContractWithCustomerExcludingAssessedTaxPercentage	0.48	pure
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2168529	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1252980	usd
	KGKG	Revenue From Contract With Customer Excluding Assessed Tax Percentage RevenueFromContractWithCustomerExcludingAssessedTaxPercentage	0.73	pure
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	511028567	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	321496788	shares
	us-gaap	Advertising Expense AdvertisingExpense	105956	usd
	us-gaap	Advertising Expense AdvertisingExpense	24100	usd
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_845_eus-gaap--ConcentrationRiskCreditRisk_zWxWZ22SJv84" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_864_z0uwaUMJG5Pe">Concentrations</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s cash balances on deposit with banks are guaranteed by the Federal Deposit Insurance Corporation (FDIC) up to $<span id="xdx_906_eus-gaap--CashFDICInsuredAmount_iI_c20220630_ziPY1e20JbNd" title="Cash FDIC insured amount">250,000</span>. Generally, the Company’s policy is to minimize borrowing costs by immediately applying cash receipts to borrowings against its credit facility. From time to time, however, the Company may be exposed to risk for the amounts of funds held in bank accounts in excess of the FDIC limit. To minimize the risk, the Company’s policy is to maintain cash balances with high quality financial institutions.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Gross sales.</i> During the three months ended June 30, 2022, the Company reported no customers that accounted for more than <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220401__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--NoCustomerMember_zAP9ui3mVfg9" title="Concentration risk percentage">10</span>% of gross sales. During the three months ended June 30, 2021, the Company reported one customer represented <span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210401__20210630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--NoCustomerMember_z80Vp1QaeMOd" title="Concentration risk percentage">30</span>% of the Company’s gross sales. During the six months ended June 30, 2022, the Company reported no customers that accounted for more than <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--NoCustomerMember_zfwQej0Z3l44" title="Concentration risk percentage">10</span>% of gross sales. During the six months ended June 30, 2021, the Company reported one customer represented <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20210630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--NoCustomerMember_zBZqWSwQvDWl" title="Concentration risk percentage">19</span>% of the Company’s gross sales.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Accounts receivable.</i> As of June 30, 2022, the Company had one customer that accounted for <span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20220630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--NoCustomerMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember_zVAtafrs8id7" title="Concentration risk percentage">15</span>% of its gross accounts receivable. As of December 31, 2021, the Company had accounts receivable from two customers that comprised <span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20211231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--TwoCustomerMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember_zRrtWwpo25Y7" title="Concentration risk percentage">60</span>% of its gross accounts receivable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Co-Packers. </i>The raw materials used in the production of the Company’s products are obtained by the Company’s co-packers and consist primarily of materials such as the flavors, caffeine, sugars or sucralose, taurine, vitamins, CBD, and hemp seed protein contained in its beverages, the bottles in which its beverages are packaged, and the labeling on the outside of its beverages. These principal raw materials are subject to price and availability fluctuations. The Company currently relies on a few key co-packers, which in turn rely on a few key suppliers. The Company continually endeavors to have back-up co-packers, which co-packers would in turn depend on their third-party suppliers to supply certain of the flavors and concentrates that are used in the Company’s beverages. The Company is also dependent on these co-packers to negotiate arrangements with their existing suppliers that would enable the Company to obtain access to certain of such concentrates or flavor formulas under certain extraordinary circumstances. Additionally, in a limited number of cases, the Company’s co-packers may have contractual restrictions with their suppliers or the Company’s co-packers may need to obtain regulatory approvals and licenses that may limit the co-packers’ ability to enter into agreements with alternative suppliers. Contractual restrictions in the agreements the Company has with certain distributors may also limit the Company’s ability to enter into agreements with alternative distributors. The Company believes that a satisfactory supply of co-packers will continue to be available at competitive prices, although there can be no assurance in this regard. The Company continually endeavors to contract with additional beverage vendors to ensure the Company has adequate inventory. The Company believes that a satisfactory supply of vendors will continue to be available at competitive prices, although there can be no assurance in this regard.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Purchases from vendors.</i> During the six months ended June 30, 2022, the Company’s largest three vendors accounted for approximately <span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20220630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchaseMember_ztOjwBzp18Z8" title="Concentration risk, percentage">32</span>%, <span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20220630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchaseMember_z3uyjgRLVLui" title="Concentration risk, percentage">20</span>%, and <span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20220630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchaseMember__srt--MajorCustomersAxis__custom--VendorThreeMember_ztKQYvRn14q5" title="Concentration risk, percentage">11</span>% of all purchases, respectively. During the six months ended June 30, 2021, the Company’s largest four vendors accounted for approximately <span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20210630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchaseMember_zhPr0rA6Es27" title="Concentration risk, percentage">33</span>%, <span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20210630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchaseMember_zVcFAm7kf5Rg" title="Concentration risk, percentage">13</span>%, <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20210630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchaseMember__srt--MajorCustomersAxis__custom--VendorThreeMember_z4WHfiuzUM5e" title="Concentration risk, percentage">12</span>%, and <span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20210630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchaseMember__srt--MajorCustomersAxis__custom--VendorFourMember_zSVcIhpUv9Y8" title="Concentration risk, percentage">11</span>% of all purchases, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Accounts payable.</i> As of June 30, 2022, three vendors accounted for more than 10% the total accounts payable. The Company’s largest four vendors accounted for <span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20220630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__srt--MajorCustomersAxis__custom--VendorOneMember_zWyB7FgBkZea" title="Concentration risk, percentage">10</span>%, <span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20220630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember_zISVsJQ6iU6j" title="Concentration risk, percentage">13</span>% and <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20220630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorThreeMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember_zwtK6mzWQDSf" title="Concentration risk, percentage">21</span>% of the total accounts payable, respectively. As of December 31, 2021, four vendors accounted for more than 10% the total accounts payable. The Company’s largest four vendors accounted for <span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20211231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__srt--MajorCustomersAxis__custom--VendorOneMember_zzPXD2XjoPvg" title="Concentration risk, percentage">20</span>%, <span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20211231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember_zWB1ESe7mL9i" title="Concentration risk, percentage">14</span>%, <span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20211231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorThreeMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember_ztrPSSUKs3G1" title="Concentration risk, percentage">12</span>%, and <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20211231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorFourMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember_zzdTtrnZd551" title="Concentration risk, percentage">11</span>% of the total accounts payable, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q2	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	9754	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	9754	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	27185	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	71078	usd
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
CY2022Q2	us-gaap	Notes Payable Current NotesPayableCurrent	198332	usd
CY2021Q4	us-gaap	Notes Payable Current NotesPayableCurrent	7974	usd
CY2022Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials	219683	usd
CY2021Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	70592	usd
CY2022Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	970230	usd
CY2021Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	504219	usd
CY2022Q2	us-gaap	Inventory Net InventoryNet	1189913	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	574811	usd
CY2022Q2	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	150000	usd
CY2021Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	150000	usd
CY2022Q2	us-gaap	Notes Payable Related Parties Current And Noncurrent NotesPayableRelatedPartiesCurrentAndNoncurrent	1728651	usd
CY2021Q4	us-gaap	Notes Payable Related Parties Current And Noncurrent NotesPayableRelatedPartiesCurrentAndNoncurrent	1531651	usd
CY2022Q2	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	1728651	usd
CY2021Q4	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	6000	usd
CY2021Q4	us-gaap	Notes Payable Related Parties Noncurrent NotesPayableRelatedPartiesNoncurrent	1525651	usd
CY2022Q2	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	99031	usd
CY2022Q2	us-gaap	Notes Payable NotesPayable	220551	usd
CY2021Q4	us-gaap	Notes Payable NotesPayable	33312	usd
CY2022Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	476326	usd
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	452158	usd
CY2022Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	148371	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	104121	usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	327955	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	348037	usd
CY2022Q2	us-gaap	Finite Lived Trademarks Gross FiniteLivedTrademarksGross	85340	usd
CY2021Q4	us-gaap	Finite Lived Trademarks Gross FiniteLivedTrademarksGross	85340	usd
CY2022Q2	KGKG	Finite Lived Gross Website Development Trademarks FiniteLivedGrossWebsiteDevelopmentTrademarks	12200	usd
CY2021Q4	KGKG	Finite Lived Gross Website Development Trademarks FiniteLivedGrossWebsiteDevelopmentTrademarks	12200	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	26462	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	21585	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	71078	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	75955	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	4877	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	4877	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	9754	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	9754	usd
CY2022Q2	us-gaap	Long Term Notes Payable LongTermNotesPayable	22219	usd
CY2021Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	25338	usd
CY2022Q2	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	833000	usd
	KGKG	Derivative Liabilities Activity DerivativeLiabilitiesActivity	3639000	usd
CY2021Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	2121000	usd
CY2022Q2	KGKG	Derivative Liabilities Secured Convertible Debentures DerivativeLiabilitiesSecuredConvertibleDebentures	680000	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-1671000	usd
CY2022Q2	us-gaap	Embedded Derivative Fair Value Of Embedded Derivative Liability EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability	3639000	usd
CY2022Q2	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	833000	usd
	us-gaap	Lease Cost LeaseCost	152841	usd
	us-gaap	Lease Cost LeaseCost	93569	usd
CY2021Q4	KGKG	Operating Lease Liabilities Right Of Use Asset OperatingLeaseLiabilitiesRightOfUseAsset	966955	usd
CY2022Q2	KGKG	Operating Leases OperatingLeases	96219	usd
CY2022Q2	KGKG	Operating Lease Liabilities Right Of Use Asset OperatingLeaseLiabilitiesRightOfUseAsset	870736	usd
CY2021Q4	KGKG	Lease Liabilities LeaseLiabilities	1052720	usd
CY2021Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	25481	usd
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	1027239	usd
	KGKG	Increase In Operating Lease IncreaseInOperatingLease	3798	usd
	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	99476	usd
CY2022Q2	us-gaap	Lease Deposit Liability LeaseDepositLiability	949446	usd
CY2022Q2	us-gaap	Finance Lease Liability FinanceLeaseLiability	21683	usd
CY2022Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	927763	usd
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	224162	usd
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	725284	usd
CY2022Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P4Y1M20D
CY2022Q2	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P2Y9M
CY2022Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.1000	pure
CY2022Q2	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0209	pure
CY2022Q2	us-gaap	Operating Leases Future Minimum Payments Remainder Of Fiscal Year OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear	154969	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	282347	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	262715	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	261083	usd
CY2022Q2	KGKG	Lessee Operating Lease Liability Payments Due Four And After Year Four LesseeOperatingLeaseLiabilityPaymentsDueFourAndAfterYearFour	198217	usd
CY2022Q2	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	1159331	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	209885	usd
CY2022Q2	KGKG	Present Value Of Net Minimum Lease Payments PresentValueOfNetMinimumLeasePayments	949446	usd
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	224162	usd
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	725284	usd
CY2022Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2022Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	988000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	988000	shares
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	2500000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	2500000000	shares
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1709122945	shares
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1709122945	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1004709546	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1004709546	shares
CY2021	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	1386497	usd
	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	1386497	usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	170000000	shares
CY2021Q4	KGKG	Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice	0.03
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted	8333333	shares
	KGKG	Share Based Compensation Arrangements By Share Based Payment Award Non Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice	0.03
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	178333333	shares
CY2022Q2	KGKG	Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice	0.03
CY2022Q2	KGKG	Share Based Compensation Arrangement By Share Based Payment Award Non Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableNumber	178333333	shares
CY2022Q2	KGKG	Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Weighted Average Exercisable Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisablePrice	0.03
CY2022Q2	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	178333333	shares
	KGKG	Class Of Warrant Or Right Number Of Use Ful Life ClassOfWarrantOrRightNumberOfUseFulLife	P1Y10M20D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Period Increase Decrease Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice	0.03
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	178333333	shares
CY2022Q2	KGKG	Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice	0.03
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	0.0086
CY2022Q2	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	8333333	shares
CY2022Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.03
CY2022Q2	KGKG	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights	0.0180

Files In Submission

Name	View Source	Status
0001493152-22-022436-index-headers.html	Edgar Link	pending
0001493152-22-022436-index.html	Edgar Link	pending
0001493152-22-022436.txt	Edgar Link	pending
0001493152-22-022436-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
kgkg-20220630.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
kgkg-20220630_def.xml	Edgar Link	unprocessable
kgkg-20220630_lab.xml	Edgar Link	unprocessable
kgkg-20220630_cal.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
kgkg-20220630_pre.xml	Edgar Link	unprocessable
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$KGKG
KONA GOLD BEVERAGE, INC. Stock $kgkg

2022 Q3 Form 10-Q Financial Statement

#000149315222022436 Filed on August 12, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$KGKG KONA GOLD BEVERAGE, INC. Stock $kgkg

2022 Q3 Form 10-Q Financial Statement

#000149315222022436 Filed on August 12, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$KGKG
KONA GOLD BEVERAGE, INC. Stock $kgkg